FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageus.nlm.vsac
Resource TypeValueSet
IdValueSet-2.16.840.1.113762.1.4.1248.119.json
FHIR VersionR4
Sourcehttps://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1248.119/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.119
Version20250211
Statusactive
Date2025-02-11T01:03:34-05:00
NameOpioidAntagonist
TitleOpioid Antagonist
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this value set is to represent concepts for the opioid antagonist medications naloxone and nalmefine administered to reverse over-administration of opioids in the hospital setting),(Data Element Scope: This value set may use a model element related to Medication),(Inclusion Criteria: Includes concepts that represent non-enteral (intranasal, intramuscular, intravenous, subcutaneous, inhalation) forms of naloxone and nalmefene medications),(Exclusion Criteria: Excludes all other types of opioid antagonists such as naltrexone. Excludes combination medications that contain both an opioid antagonist and an opioid. Excludes concepts that represent enteral (e.g., oral, gastrointestinal) forms of naloxone and nalmefene medications.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1248.119",
  "meta": {
    "versionId": "30",
    "lastUpdated": "2025-02-11T01:03:34.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "Mathematica PSI Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-02-11"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2025-02-11"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.119",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1248.119"
    }
  ],
  "version": "20250211",
  "name": "OpioidAntagonist",
  "title": "Opioid Antagonist",
  "status": "active",
  "date": "2025-02-11T01:03:34-05:00",
  "publisher": "Mathematica PSI Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for the opioid antagonist medications naloxone and nalmefine administered to reverse over-administration of opioids in the hospital setting),(Data Element Scope: This value set may use a model element related to Medication),(Inclusion Criteria: Includes concepts that represent non-enteral (intranasal, intramuscular, intravenous, subcutaneous, inhalation) forms of naloxone and nalmefene medications),(Exclusion Criteria: Excludes all other types of opioid antagonists such as naltrexone. Excludes combination medications that contain both an opioid antagonist and an opioid. Excludes concepts that represent enteral (e.g., oral, gastrointestinal) forms of naloxone and nalmefene medications.)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "1191222",
            "display": "naloxone hydrochloride 0.4 MG/ML Injectable Solution"
          },
          {
            "code": "1191234",
            "display": "1 ML naloxone hydrochloride 0.4 MG/ML Cartridge"
          },
          {
            "code": "1191250",
            "display": "2 ML naloxone hydrochloride 1 MG/ML Prefilled Syringe"
          },
          {
            "code": "1659929",
            "display": "1 ML naloxone hydrochloride 0.4 MG/ML Injection"
          },
          {
            "code": "1725059",
            "display": "naloxone hydrochloride 40 MG/ML Nasal Spray"
          },
          {
            "code": "1870933",
            "display": "naloxone hydrochloride 20 MG/ML Nasal Spray"
          },
          {
            "code": "199059",
            "display": "nalmefene 1 MG/ML Injectable Solution"
          },
          {
            "code": "2540703",
            "display": "naloxone hydrochloride 80 MG/ML Nasal Spray"
          },
          {
            "code": "2589612",
            "display": "0.5 ML naloxone hydrochloride 10 MG/ML Prefilled Syringe"
          },
          {
            "code": "2592953",
            "display": "2 ML nalmefene 1 MG/ML Injection"
          },
          {
            "code": "2596175",
            "display": "0.4 ML naloxone hydrochloride 25 MG/ML Auto-Injector"
          },
          {
            "code": "2639721",
            "display": "nalmefene 27 MG/ML Nasal Spray"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:f6cd55cf-3b91-44e6-93b0-563ddc477d98",
    "timestamp": "2025-05-23T20:53:06-04:00",
    "total": 12,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1191222",
        "display": "naloxone hydrochloride 0.4 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1191234",
        "display": "1 ML naloxone hydrochloride 0.4 MG/ML Cartridge"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1191250",
        "display": "2 ML naloxone hydrochloride 1 MG/ML Prefilled Syringe"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1659929",
        "display": "1 ML naloxone hydrochloride 0.4 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1725059",
        "display": "naloxone hydrochloride 40 MG/ML Nasal Spray"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1870933",
        "display": "naloxone hydrochloride 20 MG/ML Nasal Spray"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "199059",
        "display": "nalmefene 1 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2540703",
        "display": "naloxone hydrochloride 80 MG/ML Nasal Spray"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2589612",
        "display": "0.5 ML naloxone hydrochloride 10 MG/ML Prefilled Syringe"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2592953",
        "display": "2 ML nalmefene 1 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2596175",
        "display": "0.4 ML naloxone hydrochloride 25 MG/ML Auto-Injector"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2639721",
        "display": "nalmefene 27 MG/ML Nasal Spray"
      }
    ]
  }
}